On October 31, 2019 Indivior will host a webcast to review its YTD / Q3 results at 12:00 London time (8:00 am U.S. Eastern Time). This follows the scheduled release that day of the results at 11:00 London time (7:00 am U.S. Eastern time).
About the company IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker.
RE: Finally we have a strong recovery24 Oct 2019 08:25
150p nearly there , The business’s fifty day moving average is GBX 150.63 and its 200 day moving average is GBX 120.01. The firm has a market capitalization of $149.51 million and a P/E ratio of 8.32. The company has a current ratio of 2.59, a quick ratio of 0.82 and a debt-to-equity ratio of 5.00.